ServiceUpdated on 18 September 2024
Global Cell and Gene Therapy CDMO
About
Catalent Cell & Gene Therapy is an industry-leading Contract Development and Manufacturing Organization (CDMO) for advanced therapeutics. Our comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including CAR-T, TCR, TILs, NKs, iPSCs, and MSCs. With deep expertise in viral vector development, scale-up and manufacturing for gene therapies, Catalent is a full-service CDMO for plasmid DNA, adeno-associated viral (AAV), lentiviral and other viral vectors, oncolytic viruses, and live virus vaccines. An experienced and innovative partner, Catalent Cell & Gene Therapy has a global network of dedicated, small- and large-scale clinical and commercial manufacturing facilities, including an FDA-licensed viral vector facility, and fill/finish capabilities located in both the U.S. and Europe.
Type
- Development
- Manufacturing
Similar opportunities
Expertise
Viral vector development for gene delivery/gene therapy
Benjamin DAMIEN
CEO at SAGITTA BIOTECH
Liège, Liège, Belgium
Service
Hercule - Data-driven biomanufacuring excellence
Thibault Helleputte
CEO & co-founder at DNALYTICS
Louvain-La-Neuve, Belgium
Product
Hercule - Data-driven biomanufacuring excellence
Thibault Helleputte
CEO & co-founder at DNALYTICS
Louvain-La-Neuve, Belgium